Annual FCF
-$136.90 M
+$44.57 M+24.56%
31 December 2023
Summary:
Editas Medicine annual free cash flow is currently -$136.90 million, with the most recent change of +$44.57 million (+24.56%) on 31 December 2023. During the last 3 years, it has risen by +$50.11 million (+26.80%). EDIT annual FCF is now -1891.52% below its all-time high of -$6.87 million, reached on 31 December 2015.EDIT Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$55.51 M
+$5.05 M+8.33%
30 September 2024
Summary:
Editas Medicine quarterly free cash flow is currently -$55.51 million, with the most recent change of +$5.05 million (+8.33%) on 30 September 2024. Over the past year, it has dropped by -$19.81 million (-55.50%). EDIT quarterly FCF is now -180.29% below its all-time high of $69.14 million, reached on 31 March 2017.EDIT Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$191.35 M
-$19.81 M-11.55%
30 September 2024
Summary:
Editas Medicine TTM free cash flow is currently -$191.35 million, with the most recent change of -$19.81 million (-11.55%) on 30 September 2024. Over the past year, it has dropped by -$35.11 million (-22.47%). EDIT TTM FCF is now -836.89% below its all-time high of $25.97 million, reached on 31 March 2017.EDIT TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EDIT Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +24.6% | -55.5% | -22.5% |
| 3 y3 years | +26.8% | -28.7% | -8.8% |
| 5 y5 years | -171.3% | -90.6% | -121.8% |
EDIT Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +26.8% | -135.7% | +8.3% | -39.8% | at low |
| 5 y | 5 years | -192.3% | +26.8% | -241.1% | +8.3% | -308.6% | at low |
| alltime | all time | -1891.5% | +26.8% | -180.3% | +8.3% | -836.9% | at low |
Editas Medicine Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$55.51 M(-8.3%) | -$191.35 M(+11.5%) |
| June 2024 | - | -$60.56 M(+17.0%) | -$171.54 M(+13.6%) |
| Mar 2024 | - | -$51.74 M(+119.7%) | -$151.03 M(+10.3%) |
| Dec 2023 | -$136.90 M(-24.6%) | -$23.55 M(-34.0%) | -$136.90 M(-12.4%) |
| Sept 2023 | - | -$35.70 M(-10.9%) | -$156.25 M(-7.6%) |
| June 2023 | - | -$40.04 M(+6.5%) | -$169.17 M(+0.9%) |
| Mar 2023 | - | -$37.61 M(-12.3%) | -$167.60 M(-7.6%) |
| Dec 2022 | -$181.47 M(+5.6%) | -$42.90 M(-11.8%) | -$181.47 M(+3.1%) |
| Sept 2022 | - | -$48.62 M(+26.4%) | -$176.00 M(+3.2%) |
| June 2022 | - | -$38.48 M(-25.3%) | -$170.51 M(-1.8%) |
| Mar 2022 | - | -$51.48 M(+37.5%) | -$173.69 M(+1.1%) |
| Dec 2021 | -$171.78 M(-8.1%) | -$37.43 M(-13.2%) | -$171.78 M(-2.3%) |
| Sept 2021 | - | -$43.13 M(+3.5%) | -$175.83 M(-7.1%) |
| June 2021 | - | -$41.66 M(-15.9%) | -$189.29 M(+5.0%) |
| Mar 2021 | - | -$49.56 M(+19.5%) | -$180.33 M(-3.6%) |
| Dec 2020 | -$187.00 M(+299.3%) | -$41.48 M(-26.7%) | -$187.00 M(+76.1%) |
| Sept 2020 | - | -$56.59 M(+73.1%) | -$106.20 M(+34.9%) |
| June 2020 | - | -$32.70 M(-41.9%) | -$78.73 M(+7.3%) |
| Mar 2020 | - | -$56.24 M(-243.0%) | -$73.35 M(+56.6%) |
| Dec 2019 | -$46.84 M | $39.33 M(-235.0%) | -$46.84 M(-45.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2019 | - | -$29.13 M(+6.6%) | -$86.26 M(+30.9%) |
| June 2019 | - | -$27.32 M(-8.1%) | -$65.91 M(+16.2%) |
| Mar 2019 | - | -$29.72 M(>+9900.0%) | -$56.71 M(+12.4%) |
| Dec 2018 | -$50.46 M(+339.7%) | -$88.00 K(-99.0%) | -$50.46 M(-33.4%) |
| Sept 2018 | - | -$8.78 M(-51.6%) | -$75.73 M(-20.9%) |
| June 2018 | - | -$18.12 M(-22.8%) | -$95.68 M(-8.1%) |
| Mar 2018 | - | -$23.47 M(-7.4%) | -$104.08 M(+807.0%) |
| Dec 2017 | -$11.48 M(-78.6%) | -$25.36 M(-11.7%) | -$11.48 M(+2336.5%) |
| Sept 2017 | - | -$28.73 M(+8.3%) | -$471.00 K(-104.5%) |
| June 2017 | - | -$26.52 M(-138.4%) | $10.50 M(-59.6%) |
| Mar 2017 | - | $69.14 M(-581.7%) | $25.97 M(-148.3%) |
| Dec 2016 | -$53.74 M(+681.8%) | -$14.35 M(-19.2%) | -$53.74 M(+12.4%) |
| Sept 2016 | - | -$17.75 M(+60.5%) | -$47.80 M(+13.3%) |
| June 2016 | - | -$11.06 M(+4.6%) | -$42.17 M(+276.6%) |
| Mar 2016 | - | -$10.57 M(+25.7%) | -$11.20 M(+62.9%) |
| Dec 2015 | -$6.87 M(-30.4%) | -$8.41 M(-30.7%) | -$6.87 M(-547.8%) |
| Sept 2015 | - | -$12.13 M(-160.9%) | $1.53 M(-88.8%) |
| June 2015 | - | $19.91 M(-418.7%) | $13.66 M(-318.7%) |
| Mar 2015 | - | -$6.25 M | -$6.25 M |
| Dec 2014 | -$9.87 M | - | - |
FAQ
- What is Editas Medicine annual free cash flow?
- What is the all time high annual FCF for Editas Medicine?
- What is Editas Medicine annual FCF year-on-year change?
- What is Editas Medicine quarterly free cash flow?
- What is the all time high quarterly FCF for Editas Medicine?
- What is Editas Medicine quarterly FCF year-on-year change?
- What is Editas Medicine TTM free cash flow?
- What is the all time high TTM FCF for Editas Medicine?
- What is Editas Medicine TTM FCF year-on-year change?
What is Editas Medicine annual free cash flow?
The current annual FCF of EDIT is -$136.90 M
What is the all time high annual FCF for Editas Medicine?
Editas Medicine all-time high annual free cash flow is -$6.87 M
What is Editas Medicine annual FCF year-on-year change?
Over the past year, EDIT annual free cash flow has changed by +$44.57 M (+24.56%)
What is Editas Medicine quarterly free cash flow?
The current quarterly FCF of EDIT is -$55.51 M
What is the all time high quarterly FCF for Editas Medicine?
Editas Medicine all-time high quarterly free cash flow is $69.14 M
What is Editas Medicine quarterly FCF year-on-year change?
Over the past year, EDIT quarterly free cash flow has changed by -$19.81 M (-55.50%)
What is Editas Medicine TTM free cash flow?
The current TTM FCF of EDIT is -$191.35 M
What is the all time high TTM FCF for Editas Medicine?
Editas Medicine all-time high TTM free cash flow is $25.97 M
What is Editas Medicine TTM FCF year-on-year change?
Over the past year, EDIT TTM free cash flow has changed by -$35.11 M (-22.47%)